Press release
Meningioma Therapeutics Pipeline Insight 2018 - Clinical Trials, Patent, Collaboration and Developments
Meningioma is a type of cancer that affects the membranes surrounding the spinal cord and brain (also known as meninges). Meningioma is categorized into two types including, benign and malignant. Meningioma can be symptomatized by a headache, seizures, weakness in legs and arms, and vision loss. In some cases, carelessness, memory loss, and, unsteadiness, are also observed in some of the patients. Meningioma can also occur due to the mutation in neurofibromatosis gene (NF2).Explore Report Sample at: https://www.psmarketresearch.com/market-analysis/meningioma-therapeutics-pipeline-analysis/report-sample
One of the major risk factors for the occurrence of meningioma is the exposure of high dose ionizing radiation. Other risk factors are hormone replacement therapy, head trauma, occupational allergy, breast cancer, and family history. AstraZeneca plc is in the process of developing AZD2014 as a MTORC1 protein inhibitor for the treatment of meningioma. Novartis AG is in the process of developing ribociclib as a cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitor for the treatment of menigioma. Some of the companies having the pipeline of meningioma include GlaxoSmithKline plc, NovoCure Ltd., Novartis AG, and others.
Explore Report at: https://www.psmarketresearch.com/market-analysis/meningioma-therapeutics-pipeline-analysis
About P&S Market Research
P&S Market Research is a market research company, which offers market research and consulting services for various geographies around the globe. We provide market research reports, industry forecasting reports, business intelligence, and research based consulting services across different industry/business verticals.
As one of the top growing market research agency, we’re keen upon providing market landscape and accurate forecasting. Our analysts and consultants are proficient with business intelligence and market analysis, through their interaction with leading companies of the concerned domain. We help our clients with B2B market research and assist them in identifying various windows of opportunity, and framing informed and customized business expansion strategies in different regions.
Contact:
P&S Market Research
347, 5th Ave. #1402
New York City, NY - 10016
Toll-free: +1-888-778-7886 (USA/Canada)
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Meningioma Therapeutics Pipeline Insight 2018 - Clinical Trials, Patent, Collaboration and Developments here
News-ID: 974255 • Views: …
More Releases from P&S Market Research - Pharmaceuticals

Psoriasis Therapeutics Pipeline Analysis 2017 - Clinical Trials & Results, Paten …
The study analyzed that the psoriasis therapeutics pipeline comprises approximately 150 drug candidates in different stages of development. Psoriasis is a chronic inflammatory disorder that causes red patches covered with white scales on the skin. It is characterized when a person’s immune system sends defective signals which results in skin cells to grow rapidly. The body does not shed these excess skin cells and pile up on the surface of…

Diabetic Foot Ulcer Therapeutics Pipeline Projects Immense Growth Ahead
The study analysed that the diabetic foot ulcer pipeline comprises of approximately 27 drug candidates in different stages of development.
Explore Full Report Description At@ https://www.psmarketresearch.com/market-analysis/diabetic-foot-ulcers-therapeutics-pipeline-analysis
Diabetic foot ulcer is a serious complication of diabetes and can be defined as the ulceration in foot along with neuropathy or peripheral artery disease of the lower limb in diabetic patients. Diabetic foot ulcer is categorized into two types namely; neuropathic foot where…

Technological Advancements at Cellular and Molecular Level Strengthening the IgA …
The pipeline involves drug candidates that are being developed using specific targets such as a proliferation-inducing ligand (APRIL) and B lymphocyte stimulator (BlyS). More than three drug candidates are being developed using subcutaneous route of administration.
Explore Full Report Description At@ https://www.psmarketresearch.com/market-analysis/iga-nephropathy-pipeline-analysis
The study analyzed that the IgA nephropathy therapeutics pipeline comprises of 24 drug candidates in different stages of development. The report also includes epidemiology forecast for IgA Nephropathy for the…

Idiopathic Pulmonary Fibrosis (IPF) Therapeutics Pipeline Analysis, 2017
The study analyzed that the IPF pipeline comprised of 104 drug candidates, of which 19 drugs are in the Phase II stage of development. The lack of complete cure for IPF fuels the extensive research and development for the IPF therapeutic. There are various drugs that are being developed as novel and promising therapeutics for the treatment of IPF.
Explore Full Report Description At@ https://www.psmarketresearch.com/market-analysis/idiopathic-pulmonary-fibrosis-therapeutics-market
As per the findings of research, it…
More Releases for Meningioma
Meningioma Pipeline Appears Robust With 5+ Key Pharma Companies Actively Working …
DelveInsight's, "Meningioma Pipeline Insight 2025" report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Meningioma pipeline landscape. It covers the Meningioma pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Meningioma pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Discover the latest drugs and treatment options in the Meningioma…
Meningioma Market Report 2032: Epidemiology Analysis, Treatment drugs, FDA Appro …
DelveInsight's "Meningioma Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Meningioma, historical and forecasted epidemiology as well as the Meningioma market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
The Meningioma market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted Meningioma market size from 2019 to 2032, segmented by…
Comprehensive Analysis of Meningioma Market 2032: Epidemiological Insights, Trea …
(Albany, USA) DelveInsight's "Meningioma Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Meningioma, historical and forecasted epidemiology as well as the Meningioma market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
The Meningioma market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted Meningioma market size from 2019 to 2032,…
Meningioma Market Report 2032: Epidemiology Analysis, Treatment drugs, FDA Appro …
(Albany, USA) DelveInsight's "Meningioma Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Meningioma, historical and forecasted epidemiology as well as the Meningioma market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
The Meningioma market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted Meningioma market size from 2019 to…
Meningioma Market is Expected to Show a Healthy Growth Rate During the Study Per …
DelveInsight's "Meningioma Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Meningioma, historical and forecasted epidemiology as well as the Meningioma market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.
Download Sample Report to know more @ https://www.delveinsight.com/sample-request/meningioma-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr
Meningioma Overview
Meningioma, also known as meningeal tumor, is typically a slow-growing tumor that forms from the meninges, the membranous layers surrounding the…
Meningioma Market to Witness Growth by 2032, Estimates DelveInsight | Companies- …
DelveInsight's "Meningioma Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Meningioma, historical and forecasted epidemiology as well as the Meningioma market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
The Meningioma market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted Meningioma market size from 2019 to 2032, segmented…